comparemela.com

Latest Breaking News On - Zhiqiang shu - Page 3 : comparemela.com

BIONTECH : Berenberg reiterates its Buy rating

Analyst Zhiqiang Shu from Berenberg research considers the stock attractive and recommends it with a Buy rating. The target price is decreased from USD 300 to USD 260. | March 28, 2023

StockWatch: Antitrust Fears Dampen Support for $43B Pfizer-Seagen Deal

StockWatch: Pfizer Scales Patent Cliff by Pursuing Seagen Deal

StockWatch: Pfizer Scales Patent Cliff by Pursuing Seagen Deal
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

StockWatch: Pfizer Scales Patent Cliff by Pursuing Seagen Deal

StockWatch: Pfizer Scales Patent Cliff by Pursuing Seagen Deal
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Pfizer discussing multi-billion dollar purchase of cancer drugmaker

Pfizer discussing multi-billion dollar purchase of cancer drugmaker
shanghainews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from shanghainews.net Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.